Decrease of resistance to imatinib in leukaemia

被引:4
作者
Gambacorti-Passerini, C [1 ]
机构
[1] Natl Canc Inst, Oncogen Fus Prot Unit, I-20133 Milan, Italy
关键词
D O I
10.1016/S0140-6736(02)08623-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1777 / 1777
页数:1
相关论文
共 5 条
[1]  
Gambacorti-Passeri C, 2001, BLOOD, V98, p309A
[2]  
GAMBACORTIPASSE.C, 2001, SCIENCE, V293, P2163
[3]   Resistance to targeted therapy in leukaemia [J].
Griffin, JD .
LANCET, 2002, 359 (9305) :458-459
[4]  
Larghero J, 2001, BLOOD, V98, p616A
[5]   Determination of α-1 acid glycoprotein in patients with Ph plus chronic myeloid leukemia during the first 13 weeks of therapy with STI571 [J].
le Coutre, P ;
Kreuzer, KA ;
Na, IK ;
Lupberger, J ;
Holdhoff, M ;
Appelt, C ;
Schwarz, M ;
Müller, C ;
Gambacorti-Passerini, C ;
Platzbecker, U ;
Bonnet, R ;
Ehninger, G ;
Schmidt, CA .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (01) :75-85